| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/18/2009 | EP2119778A1 Method for activation of helper t cell and composition for use in the method |
| 11/18/2009 | EP2119738A1 Polyethylene glycol derivative |
| 11/18/2009 | EP2119720A1 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives |
| 11/18/2009 | EP2119718A1 Macrocyclic compound |
| 11/18/2009 | EP2119707A1 Composition for treatment of undifferentiated-type of gastric cancer |
| 11/18/2009 | EP2119706A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene |
| 11/18/2009 | EP2119453A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
| 11/18/2009 | EP2119434A1 Use of heterosidic flavonoid derivatives for therapy of stem cell cancers |
| 11/18/2009 | EP2118318A2 Gnaq mutations in melanoma |
| 11/18/2009 | EP2118133A2 Amelioration of cellular stress response |
| 11/18/2009 | EP2118118A2 Mediated cellular delivery of lna oligonucleotides |
| 11/18/2009 | EP2118117A2 Solid state forms of 5-azacytidine and processes for preparation thereof |
| 11/18/2009 | EP2118107A1 Mercaptopurine derivatives as anticancer agents |
| 11/18/2009 | EP2118088A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer |
| 11/18/2009 | EP2118087A1 Pi 3-kinase inhibitors and methods of their use |
| 11/18/2009 | EP2118079A1 Synthetic macrocyclic compounds for treating cancer |
| 11/18/2009 | EP2118075A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
| 11/18/2009 | EP2118072A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 11/18/2009 | EP2118069A2 Bis-aryl amide derivatives useful for the treatment of cancer |
| 11/18/2009 | EP2118065A1 Novel substituted 1h-benz ýde¨isoquinoline-1, 3 -diones |
| 11/18/2009 | EP2117598A2 Formulations of deacetylase inhibitors |
| 11/18/2009 | EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 11/18/2009 | EP2117591A1 Reducing tumor growth |
| 11/18/2009 | EP2117579A1 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 11/18/2009 | EP2117557A2 Compositions and methods for treatment of colorectal cancer |
| 11/18/2009 | EP2117555A1 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
| 11/18/2009 | EP2117548A1 Method of treating multidrug resistant cancers |
| 11/18/2009 | EP2117539A1 A method of administering an antitumor compound |
| 11/18/2009 | EP2117523A1 Inhibitors of akt activity |
| 11/18/2009 | EP2117520A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 11/18/2009 | EP1858836B1 Analogues of the azinomycins as anti-tumour agents and as prodrugs |
| 11/18/2009 | EP1587474B1 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 11/18/2009 | EP1490064B1 Substituted pyridinones as modulators of p38 map kinase |
| 11/18/2009 | EP1463541B1 Biomaterials based on hyaluronic acid benzyl ester for the anti-angiogenic therapy in the treatment of tumours |
| 11/18/2009 | EP1453977B1 Molecular characteristics of non-small cell lung cancer |
| 11/18/2009 | EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 11/18/2009 | EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use |
| 11/18/2009 | EP1332214B1 32144, a human fatty acid amide hydrolase and uses thereof |
| 11/18/2009 | EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals |
| 11/18/2009 | EP1079875B2 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 11/18/2009 | EP0960127B1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 11/18/2009 | EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 11/18/2009 | EP0892789B2 Irreversible inhibitors of tyrosine kinases |
| 11/18/2009 | CN101583715A Inhibitory polynucleotide compositions and methods for treating cancer |
| 11/18/2009 | CN101583714A Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases |
| 11/18/2009 | CN101583616A Aza-benzothiophenyl compounds and methods of use |
| 11/18/2009 | CN101583606A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 11/18/2009 | CN101583605A Triazole derivative as an HSP 90 inhibitor |
| 11/18/2009 | CN101583603A Aromatic 1,4-di-carboxylamides and their use |
| 11/18/2009 | CN101583366A Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 11/18/2009 | CN101583359A Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 11/18/2009 | CN101583357A Composition of mTOR antagonist and angiogenesis inhibitor for treating cancer |
| 11/18/2009 | CN101580850A Specificity expression marker gene on telomerase masculine tumor cell, slow virus for curing gene and application thereof |
| 11/18/2009 | CN101580845A Vector capable of inducing cancer cell-apoptosis and use thereof |
| 11/18/2009 | CN101580821A 2-naphthoic monooxygenase for preparing anti-cancer medicament indigo red |
| 11/18/2009 | CN101580817A Method for preparing cell group containing cytokine-induced killing cell |
| 11/18/2009 | CN101580805A Brefeldin A-producing bacteria and method for preparing brefeldin A by fermentation |
| 11/18/2009 | CN101580755A Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris |
| 11/18/2009 | CN101580548A Fusion peptide for inhibiting tumor growth and application thereof in preparing anti-tumor medicament |
| 11/18/2009 | CN101580538A WT1-origin HLA-DR-binding antigen peptide |
| 11/18/2009 | CN101580510A Artemisinin derivatives and application thereof |
| 11/18/2009 | CN101580507A Novel antitumor compound and preparation method and application thereof |
| 11/18/2009 | CN101580477A Dehydroabietylamine derivatives and application thereof in bactericidal and antineoplastic medicaments |
| 11/18/2009 | CN101580460A Synthesis method of 3, 4-dihydroxy phenylethanol |
| 11/18/2009 | CN101579520A Aplidine for the treatment of multiple myeloma |
| 11/18/2009 | CN101579519A Capsule or oral liquid of traditional Chinese medicine for preventing and treating gastric cancer |
| 11/18/2009 | CN101579497A Traditional Chinese medicine preparation for curing cancer |
| 11/18/2009 | CN101579496A Application of Chinese medicine composition in preparation of medicine for treating atypical hyperplasia of gastric mucosa |
| 11/18/2009 | CN101579478A Effective component composite with anti-tumor activity of traditional Chinese medicine compound five components and preparation method thereof |
| 11/18/2009 | CN101579424A Chinese herbal medicine preparation for treating cancer |
| 11/18/2009 | CN101579365A Edible fungus tumor health capsule and preparation method thereof |
| 11/18/2009 | CN101579362A Compositions and method for tumor-target delivery of effect molecules |
| 11/18/2009 | CN101579352A Application of polysaccharide component of longan pulp in pharmacy |
| 11/18/2009 | CN101579345A 5-methylcytosine deoxycytidylic acid for inhibiting cancer gene |
| 11/18/2009 | CN101579335A New formulation of medicament, preparation method and application method |
| 11/18/2009 | CN101579328A Application of combretastatin |
| 11/18/2009 | CN101579314A Anti-cancer drug sustained-release preparation of organic-inorganic complex liposome and preparation method thereof |
| 11/18/2009 | CN101579312A Teniposide liposome and preparation method thereof |
| 11/18/2009 | CN101579310A Decataxel self-microemulsifying composition and preparation method thereof |
| 11/18/2009 | CN100561229C A cytocapacity test |
| 11/18/2009 | CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 11/18/2009 | CN100560606C Mussel glucan and its preparation method and application |
| 11/18/2009 | CN100560601C Derivative of cyclosporins C and D and pharmaceutical composition thereof |
| 11/18/2009 | CN100560587C Antineoplastic activity canthardin derivant and method of preparing the same |
| 11/18/2009 | CN100560586C Derivative of folacin alkylation and application |
| 11/18/2009 | CN100560572C Alkaline amino acid salt of Glycididazole acid, preparation and application |
| 11/18/2009 | CN100560568C Cyclin imide peptidyl metalloprotease inhibitor and its application |
| 11/18/2009 | CN100560137C Bacteria nano magnetosome loaded with primary amine medicine and preparation method thereof |
| 11/18/2009 | CN100560136C Ferrite/bacille calmette-guerin vaccine/temperature sensing gel integration material and preparation thereof |
| 11/18/2009 | CN100560133C Nanometer magnetic polylactic acid-phenyl arsine glycollate microballoon and its pharmaceutical use |
| 11/18/2009 | CN100560131C Antibody targeting compounds |
| 11/18/2009 | CN100560130C Tumor antigen based on products of the tumor suppressor gent WT1 |
| 11/18/2009 | CN100560091C Cancer treating Chinese medicine preparation |
| 11/18/2009 | CN100560087C Medicine for curing malignant tumor and its preparation method |
| 11/18/2009 | CN100560081C Method for extracting flavonoids from the waxberry core |
| 11/17/2009 | US7619100 Physiologically active substances |
| 11/17/2009 | US7619083 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 11/17/2009 | US7619080 Oligonucleotides of a chicken leukemia inhibitory factor (LIF) gene |
| 11/17/2009 | US7619065 Cystine-knot fold protein |
| 11/17/2009 | US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |